ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0797

Spatial transcriptomics identifies density-sensing fibroblasts in synovial lining

Sonia Presti1, Kseniia Anufrieva2, Ce Gao3, Sean Prell2, Philip Blazar2, Jeffrey Lange2, Morgan Jones2, Mihir Wechalekar4, Michael Brenner2, Ilya Korsunsky5, Shideh Kazerounian2 and Kevin Wei6, 1Standford University, Stanford, 2Mass General Brigham, Boston, 3Division of Rheumatology, Inflammation and Immunity, DOM, BWH; Harvard Medical School, Boston, MA, 4Flinders Medical Centre, Adelaide, Australia, 5Division of Rheumatology, Inflammation and Immunity, DOM, BWH; Division of Genetics, DOM, BWH; Harvard Medical School, Boston, MA, 6Brigham and Women's Hospital at Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2025

Keywords: Bioinformatics, Cell-signalling molecules, Fibroblasts, Synovial, Gene Expression, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: Abstracts: Rheumatoid Arthritis – Etiology and Pathogenesis (0795–0800)

Session Type: Abstract Session

Session Time: 1:30PM-1:45PM

Background/Purpose: The synovial lining is crucial for joint homeostasis, forming a barrier and producing lubricants through specialized fibroblasts. These fibroblasts differ from sublining fibroblasts, which are involved in inflammation and matrix remodeling. While vascular Notch signaling helps define vascular fibroblast positional identity (Wei et al. 2020), the factors shaping synovial lining fibroblast identity are unclear. Using spatial transcriptomics on synovial biopsies from RA patients in remission, we identify a density-dependent mechanism regulating lining fibroblast identity and suggest CREB5, SOX5, and FOXO1 as key transcriptional regulators.

Methods: Synovial tissue and synovial fibroblast micromasses were processed using the Xenium In Situ Gene Expression protocol (10X Genomics, CG000582 Rev D) with a custom 400-gene panel(Bhamidipati et al. 2025). For bulk RNA-seq and qRT-PCR, synovial fibroblasts were seeded at densities of 75–600 cells/mm² in 96-well plates for 3 days. For siRNA knockdown, cells were transfected with siRNA at 200K/well in 6-well plates and then re-seeded at varying densities.

Results: Spatial transcriptomics identified two fibroblast clusters in synovial tissue from RA patients in clinical remission: lining fibroblasts in dense, peripheral regions and sublining fibroblasts in less dense, central areas. A similar spatial organization was observed in synovial fibroblast micromass cultures maintained for 21 days. Extended culture led to increased accumulation of sublining fibroblasts in the central region, while lining fibroblasts remained localized to the periphery. Among the genes enriched in high-density regions of synovial tissue and fibroblast micromass cultures were the transcription factors CREB5, SOX5, and FOXO1, which exhibited spatial distribution patterns similar to canonical lining markers (PRG4, CLU, PDPN). These factors emerged as key candidates for regulating fibroblast identity. In vitro knockdown of CREB5 significantly reduced lining marker expression and increased sublining markers in a density-dependent manner. Similarly, knockdown of SOX5 and FOXO1 decreased lining marker expression without significantly affecting sublining marker levels.

Conclusion: In summary, our findings identify a density-responsive subset of lining fibroblasts defined by elevated CREB5, SOX5, and FOXO1 expression. We propose that increased cell density may activate as-yet-unidentified upstream signaling pathways that modulate the expression and/or activity of CREB5, FOXO1, and SOX5. Acting individually or synergistically, these transcription factors appear to mediate a cell density–dependent phenotypic transition from sublining to lining fibroblast states, thereby contributing to fibroblast identity.

Supporting image 1Figure 1. Characterization of fibroblast populations in RA synovial tissue and synovial fibroblast micromass culture system

Supporting image 2Figure 2. Bulk RNA-seq analysis of CREB5 KD (A-F) and qRT-PCR analysis of SOX5 and FOXO1 KD in synovial fibroblasts


Disclosures: S. Presti: None; K. Anufrieva: None; C. Gao: None; S. Prell: None; P. Blazar: Endo Pharmaceuticals, 2; J. Lange: Cambridge Scholars Publishing, 9, OnPoint Knee, 1, 9, Smith and Nephew, 2; M. Jones: Grunenthal, 1, Pacira, 5; M. Wechalekar: GlaxoSmithKlein(GSK), 5, Janssen, 5; M. Brenner: None; I. Korsunsky: Mestag Therapeutics, 2; S. Kazerounian: None; K. Wei: 10X Genomics, 5, anaptysbio, 2, Gilead, 5, Merck/MSD, 5, Mestag, 2, Pfizer, 2.

To cite this abstract in AMA style:

Presti S, Anufrieva K, Gao C, Prell S, Blazar P, Lange J, Jones M, Wechalekar M, Brenner M, Korsunsky I, Kazerounian S, Wei K. Spatial transcriptomics identifies density-sensing fibroblasts in synovial lining [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/spatial-transcriptomics-identifies-density-sensing-fibroblasts-in-synovial-lining/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/spatial-transcriptomics-identifies-density-sensing-fibroblasts-in-synovial-lining/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology